Literature DB >> 28387894

The natural history of prehypertension. A 20-year follow-up.

G Pannarale1, C Moroni, M C Acconcia, G Pannitteri, G Truscelli, L Valente, P Gentile, F Lopreiato, R Licitra, M Tancredi, P E Puddu, M L Troccoli, P Cardelli, F Barillà, C Gaudio.   

Abstract

OBJECTIVE: According to the JNC7 report, prehypertension category includes subjects with systolic blood pressure between 120 and 139 mmHg and/or diastolic blood pressure between 80 and 89 mmHg that would be at risk for developing hypertension and its untoward sequelae as myocardial infarction and cerebrovascular disease. Moreover, ambulatory blood pressure monitoring made it possible to detect subjects with masked hypertension, who are at risk of greater target organ damage than those with normal ambulatory or home blood pressure. The aim of this study was to evaluate the risk of cardiac, cerebral and vascular events in a group of prehypertensive subjects, with and without masked hypertension. PATIENTS AND METHODS: We studied 204 consecutive asymptomatic prehypertensive subjects without history and signs of cardiovascular disease or diabetes. All the subjects underwent clinical evaluation, electrocardiogram, routine laboratory tests and ambulatory blood pressure monitoring. They were followed-up for a maximum of 237 months or until a cardiovascular event occurred.
RESULTS: Twenty-seven cardiovascular events (13.2%) occurred, including 4 abdominal aortic aneurysms. Age (p<0.0001), total cholesterol (p=0.004), smoking (p=0.03) and clinically overt hypertension development (p=0.011) were related to cardiovascular events. Prognosis was not related to masked hypertension.
CONCLUSIONS: The results of this study suggest that, in subjects with prehypertension, followed for 20 years, traditional cardiovascular risk factors and development of clinically overt hypertension could be more relevant than ambulatory hypertension in the prediction of an adverse outcome.

Entities:  

Mesh:

Year:  2017        PMID: 28387894

Source DB:  PubMed          Journal:  Eur Rev Med Pharmacol Sci        ISSN: 1128-3602            Impact factor:   3.507


  5 in total

1.  Improvement of postoperative cognitive dysfunction and attention network function of patients with ischemic cerebrovascular disease via dexmedetomidine.

Authors:  Jingchao Zhang; Guoliang Wang; Fangxiang Zhang; Qian Zhao
Journal:  Exp Ther Med       Date:  2018-01-30       Impact factor: 2.447

2.  Correlation analysis of intestinal flora with hypertension.

Authors:  Jilun Liu; Ning An; Cong Ma; Xiaofeng Li; Jie Zhang; Wei Zhu; Yihe Zhang; Junpeng Li
Journal:  Exp Ther Med       Date:  2018-07-20       Impact factor: 2.447

3.  A longitudinal analysis of the progression from normal blood pressure to stage 2 hypertension: A 12-year Korean cohort.

Authors:  Eun Sun Yu; Kwan Hong; Byung Chul Chun
Journal:  BMC Public Health       Date:  2021-01-06       Impact factor: 3.295

4.  Indicators of accumulated fat are stronger associated with prehypertension compared with indicators of circulating fat: A cross-sectional study.

Authors:  Susana Rivera-Mancía; Eloisa Colín-Ramírez; Raúl Cartas-Rosado; Oscar Infante; Jesús Vargas-Barrón; Maite Vallejo
Journal:  Medicine (Baltimore)       Date:  2018-08       Impact factor: 1.817

5.  Risk factors of the progression to hypertension and characteristics of natural history during progression: A national cohort study.

Authors:  Kwan Hong; Eun Sun Yu; Byung Chul Chun
Journal:  PLoS One       Date:  2020-03-17       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.